Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management. We market a portfolio of revenue generating products consisting of prescription pharmaceuticals and a line of prenatal vitamins, and we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne's focus areas.
We are developing: Zipsor™ for the treatment of mild to moderate acute pain for which we have received an Approvable Letter from the U.S. Food & Drug Administration (FDA); XP12B for the treatment of menorrhagia (heavy menstrual bleeding) has recently received top line Phase 3 clinical data and NDA filing is being completed; and XP20B for the treatment of mild to moderate pain for which a Phase 3 trial has been completed in the U.S.
|
|
|
|
|
11-50 employees
View all Xanodyne Pharmaceuticals employees
|
|
|
Pharmaceuticals
|
|
|
One Riverfront Plaza, Newport, Kentucky, US
|
|
|
Pain Management And Women's Health
|
The decision makers in Xanodyne Pharmaceuticals are Dave Spinale, Gary Shangold, Jonathan Kafer, etc. Click to Find Xanodyne Pharmaceuticals decision makers emails.
You can reach Xanodyne Pharmaceuticals by visiting our website's contact page, where you'll find a contact form and our customer service email. For urgent inquiries, please call our main office number listed on the site during business hours.
Yes, Xanodyne Pharmaceuticals provides a staff directory on our website. This directory includes key personnel in various departments, allowing you to find the right contact for your specific needs related to women's healthcare and pain management.
Xanodyne Pharmaceuticals specializes in developing and marketing prescription pharmaceuticals focused on women's health and pain management. Our services include product development, regulatory support, and commercial distribution to ensure our products reach those who need them.
Xanodyne Pharmaceuticals primarily supports the healthcare industry, specifically focusing on women's health and pain management sectors. Our products are designed to address the unique needs of these areas, providing effective solutions for patients and healthcare providers.
Yes, detailed information about our product portfolio is available on our website. We offer a range of prescription pharmaceuticals aimed at pain management and women's health, including product descriptions, indications, and usage guidelines.
For partnership inquiries, please contact our business development team through the contact form on our website. We welcome collaborations that align with our mission in women's healthcare and pain management, and we look forward to exploring potential opportunities.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.